Verified Novel Coronavirus Diagnostic Kits

On March 11, 2020 the World Health Organization (WHO) declared COVID-19 a global pandemic that has infected more than 120,000 people leading to 11,000 deaths in over 185 countries around the world.

Accurate and widely available diagnostic testing kits are critical to mitigating the spread of COVID-19. Kahala Biosciences is committed to meeting the growing demand for testing kits throughout North America by bringing the Logix Smart™ COVID-19 test kit to those who need it most.

Kahala Biosciences LLC (Irvine, CA) was formed to respond to the rapid spread of COVID-19 and to meet the urgent demand for effective and widely available testing kits across North America



The Kahala Logix Smart™ COVID-19 Test uses a patented CoPrimer™ single step real-time RT-PCR process to facilitate the processing of up to 382 patient samples per hour.


Its qualitative multiplex PCR detection of SARS-CoV-2 (COVID-19) gene RdRp has 100% sensitivity and 100% specificity.


Employs standard and widely available laboratory tools and equipment without needing to transport it to a distant location, which can lead to delays in diagnosis.